Eat, Sleep, Console (ESC) Assessment

Why use it

Significantly reduces pharmacotherapy use, length of hospital stay, and NICU admissions compared to FNAS-based care. Promotes parental involvement and rooming-in — validated to improve outcomes. Simpler and more intuitive than FNAS, reducing inter-rater variability. Endorsed by AAP 2023 clinical guidance as a preferred approach.

About

Eat, Sleep, Console (ESC) is a function-based assessment approach for neonatal opioid withdrawal syndrome (NOWS), formerly known as neonatal abstinence syndrome (NAS). Unlike the Finnegan Neonatal Abstinence Score (FNAS), which uses a complex 21-item scoring system tied to fixed pharmacotherapy thresholds, ESC focuses on three fundamental neonatal functions: the ability to eat (≥1 oz or breastfeed well per feeding), sleep (≥1 hour between feedings), and be consoled (within 10 minutes). ESC was developed at Dartmouth-Hitchcock Medical Center and validated in a multicenter implementation study. The approach emphasizes non-pharmacological care (NPC), parental involvement, rooming-in, and minimizing pharmacotherapy. The landmark ESC Care Tool (ACT) trial (NEJM Evidence 2023) demonstrated ESC leads to significantly less pharmacotherapy, shorter hospital stays, and equivalent safety outcomes compared to FNAS-based care.

When to use

• All neonates born to mothers with opioid use disorder or those receiving opioid maintenance therapy (methadone, buprenorphine)
• Neonates exposed in utero to opioids, regardless of maternal prescribed vs. illicit use
• Assessment every 3–4 hours in the first 5–7 days of life for opioid-exposed neonates
• Guiding decision to escalate to pharmacotherapy in neonates not meeting ESC criteria

Formula

Pearls & pitfalls

• ESC reduces pharmacotherapy rates by 63% and length of stay by 4–8 days compared to FNAS — the most impactful change in NOWS care in decades.
• Breastfeeding (if mother is stable on opioid maintenance therapy without other contraindications) reduces NOWS severity and should be supported regardless of methadone/buprenorphine dose.
• Rooming-in allows parents to be primary caregivers and ESC assessors — parental presence reduces pharmacotherapy rates by 50%.
• "Console within 10 minutes" starts AFTER parental or nursing soothing efforts have been applied. A neonate who self-soothes also passes.
• Tremors, high-pitched cry, and autonomic symptoms (sweating, mottling) are captured indirectly through the three ESC criteria — if these symptoms prevent eating, sleeping, or consoling, pharmacotherapy is indicated.
• ESC-based discharge requires: all three criteria met for 24 hours, ability to feed adequately, safe home environment confirmed, close outpatient follow-up arranged.
• FNAS is still used in some centers and for non-opioid withdrawal (alcohol, benzodiazepines). ESC is specifically validated for opioid withdrawal.
• All opioid-exposed neonates should receive at least 5 days of observation before discharge (may be 5–7 days depending on exposure type).

Next steps

All three criteria MET (Can eat ≥1 oz, sleep ≥1h, console within 10 min): Continue non-pharmacological care (NPC). Maximize rooming-in, breastfeeding if appropriate, skin-to-skin, pacifier, swaddling. Any criterion NOT MET: (1) Maximize NPC for one additional feeding cycle. (2) If still failing after NPC optimization, initiate pharmacotherapy with morphine or methadone per protocol. (3) Involve parents in all assessments — parental soothing as first-line consoling intervention. Discharge planning: minimum 5 days observation if opioid-exposed; ESC-based discharge is safe when all criteria consistently met.

Evidence

Grossman MR et al. An initiative to improve the quality of care of infants with neonatal abstinence syndrome. Pediatrics. 2017;139(6):e20163360. Montgomery Cooper DW et al. Eat, Sleep, Console Approach or Usual Care for Neonatal Opioid Withdrawal. NEJM Evidence. 2023. Multicenter RCT showed ESC reduced pharmacotherapy from 52% to 28% and length of stay from 15.5 to 8.2 days. AAP Clinical Report 2023 endorses ESC.

References

1. Grossman MR et al. An Initiative to Improve the Quality of Care of Infants with Neonatal Abstinence Syndrome. Pediatrics. 2017;139(6):e20163360. — link
2. Montgomery Cooper DW et al. Eat, Sleep, Console Approach or Usual Care for Neonatal Opioid Withdrawal. NEJM Evidence. 2023;2(3). — link
3. Patrick SW et al. Neonatal Opioid Withdrawal Syndrome: An Update on Epidemiology, Diagnosis, Treatment, and Prevention. Pediatrics. 2023;151(2):e2022059422. — link